Engrailed-1 and Epigenetic Vulnerabilities in Metastatic Pancreatic Cancer
转移性胰腺癌中的 Engrailed-1 和表观遗传脆弱性
基本信息
- 批准号:10211256
- 负责人:
- 金额:$ 34.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-03-08 至 2026-02-28
- 项目状态:未结题
- 来源:
- 关键词:AbbreviationsAddressAllelesAutomobile DrivingBiomimeticsBiopsyBlood VesselsCaliforniaChIP-seqCharacteristicsCoculture TechniquesComplexComprehensive Cancer CenterDNA MethylationDataData AnalysesDevelopmentDiseaseDisease ProgressionDisseminated Malignant NeoplasmEndometrial CarcinomaEnhancersEpigenetic ProcessEpithelialGene ExpressionGene Expression RegulationGene set enrichment analysisGenesGenetic TranscriptionGenetically Engineered MouseGliomaHumanIn VitroIncidenceInjectionsInvestigationLeadLungMalignant NeoplasmsMalignant neoplasm of ovaryMalignant neoplasm of pancreasMediatingMesenchymalModelingMolecularMusNatureNeoplasm MetastasisOrganoidsPancreasPancreatic Ductal AdenocarcinomaPancreatic Intraepithelial NeoplasiaPathway interactionsPatientsPlayProcessPrognosisPropertyPublic HealthRenal carcinomaResectedResistanceRoleSamplingSolid NeoplasmStomachSurgical ModelsSystemTailThe Cancer Genome AtlasTherapeuticThyroid GlandTranscription RepressorTumor-DerivedUnited StatesUniversitiesUrotheliumVeinsbisulfite sequencingcancer cellcancer typechromatin immunoprecipitationchromatin remodelingconditional knockouteffective therapyepigenomegenetic signaturehomeodomainimprovedin vivoinsightloss of functionmolecular subtypesmortalitymouse modelneurodevelopmentnext generation sequencingnovelnovel therapeutic interventionpancreatic cancer cellspancreatic cancer patientspancreatic ductal adenocarcinoma modelpatient derived xenograft modelrecruitresponsesingle-cell RNA sequencingtraittranscription factortranscriptome sequencingtranscriptomicstransplant modeltreatment strategytumor progression
项目摘要
Project Summary/Abstract
Pancreatic cancer is the most deadly disease in human malignancies and effective treatment
options are limited. Here, we hypothesize that Engrailed-1 (EN1), a neuro-development
transcription factor, plays a critical role in pancreatic cancer progression and metastasis via
epigenetic mechanism of gene regulation. EN1 is a homeo-domain transcription factor, acting as
a transcriptional repressor via recruiting transcriptional repressive complexes. Our preliminary
data show that EN1 is highly expressed in metastasis-derived organoids and metastatic lesions
of pancreatic cancer mouse model. In addition, EN1 expression is associated with poor prognosis
and the squamous molecular subtype of pancreatic cancer. Here, we find that EN1 expression
endows aggressive characteristics to pancreatic cancer cells and induces the squamous-PDA
identity gene signature. Our data strongly suggest that EN1-mediated epigenetic alterations
create a new vulnerability for metastatic pancreatic cancer. Therefore, it is critical to identify the
underlying molecular mechanism by which EN1 regulates pancreatic epigenome and contributes
to PDA progression and metastasis. To address this, we will employ multi-orthogonal approaches
to understand the precise role of EN1 in PDA progression. Here, we propose 1) to determine the
role of EN1 in the pancreatic cancer epigenome, and 2) to determine the role of EN1 in pancreatic
cancer progression. The proposed study will provide a new insight how EN1-mediated epigenetic
alterations impact on aggressive traits of pancreatic cancer. This may open novel avenues for the
treatment of pancreatic cancer.
项目总结/摘要
胰腺癌是人类恶性肿瘤中死亡率最高的疾病,治疗效果最好
选择有限。在这里,我们假设Engrailed-1(EN 1),一种神经发育
在胰腺癌的进展和转移中起着关键作用,
基因调控的表观遗传机制。EN 1是一种同源结构域转录因子,
通过募集转录抑制复合物来抑制转录。我们的初步
数据显示EN 1在转移源性类器官和转移性病变中高度表达
胰腺癌小鼠模型。此外,EN 1表达与不良预后相关
和胰腺癌的鳞状分子亚型。在这里,我们发现EN 1表达
赋予胰腺癌细胞侵袭性,诱导鳞状PDA
身份基因签名。我们的数据强烈提示EN 1介导的表观遗传改变
为转移性胰腺癌创造了新的弱点因此,确定
EN 1调节胰腺表观基因组并促进胰腺癌发生的潜在分子机制
与PDA进展和转移有关。为了解决这个问题,我们将采用多正交方法
了解EN 1在PDA进展中的确切作用。在这里,我们建议1)确定
EN 1在胰腺癌表观基因组中的作用,和2)确定EN 1在胰腺癌表观基因组中的作用,
癌症进展这项研究将为EN 1介导的表观遗传学提供新的见解。
改变影响胰腺癌的侵袭性特征。这可能会打开新的途径,
胰腺癌的治疗
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Chang-il Hwang其他文献
Chang-il Hwang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Chang-il Hwang', 18)}}的其他基金
Engrailed-1 and Epigenetic Vulnerabilities in Metastatic Pancreatic Cancer
转移性胰腺癌中的 Engrailed-1 和表观遗传脆弱性
- 批准号:
10368153 - 财政年份:2021
- 资助金额:
$ 34.61万 - 项目类别:
Engrailed-1 and Epigenetic Vulnerabilities in Metastatic Pancreatic Cancer
转移性胰腺癌中的 Engrailed-1 和表观遗传脆弱性
- 批准号:
10577889 - 财政年份:2021
- 资助金额:
$ 34.61万 - 项目类别:
The Characterization of the New Tumor Suppressor USP9X in Pancreatic Cancer
新型肿瘤抑制剂 USP9X 在胰腺癌中的表征
- 批准号:
8835986 - 财政年份:2015
- 资助金额:
$ 34.61万 - 项目类别:
The Characterization of the New Tumor Suppressor USP9X in Pancreatic Cancer
新型肿瘤抑制剂 USP9X 在胰腺癌中的表征
- 批准号:
9015258 - 财政年份:2015
- 资助金额:
$ 34.61万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 34.61万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 34.61万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 34.61万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 34.61万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 34.61万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 34.61万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 34.61万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 34.61万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 34.61万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 34.61万 - 项目类别:
Research Grant